A report has just recently been released from the World Health Organization (WHO), and it is very good news for CBD (Cannabidiol) aka hemp oil and its users. The WHO report says that they have found no adverse health issues but rather several medicinal applications for CBD. This finding clashes with the current U.S. Federal policy regarding cannabidiol.


According to the WHO report, natural occurring CBD is not only safe, but well tolerated in people and animals. They found that it is in no way associated with any negative health effects.


Experts found that CBD, the NON-PSYCHOACTIVE chemical found in cannabis (from which CBD is cultivated), does not cause any physical dependence and is also “not associated with abuse potential.” The WHO also stated, that unlike THC (Tetrahydrocannabinol), people get can’t get “high” from CBD.


“To date, there is no evidence of recreational use of CBD or any public health related problems associated with the use of pure CBD,” they wrote. In fact, evidence suggests that CBD mitigates the effects of THC (whether joyous or panicky), according to this report.


The authors of the finding pointed out that research has officially confirmed some positive effects of the chemical, however. They determined that CBD has “been demonstrated as an effective treatment for epilepsy” in adults, children, and even animals, and that there’s even “preliminary evidence” that CBD could be useful in treating Alzheimer’s disease, cancer, psychosis, Parkinson’s disease, and other serious conditions. The report continued, “Several countries have modified their national controls to accommodate CBD as a medicinal product.”


Unfortunately, the United States is not one of those countries, the report noted. According to U.S. Drug Law, it is stated that as a cannabis component, CBD remains classified as a Schedule I controlled substance. This means it has a “high potential for abuse”.


The findings also made a valuable point in that while CBD itself is safe, and found to be helpful for many users, experts have cautioned that not all CBD extracts are created equally, purely, or with the same methods of extraction.


While reports of negative reactions to pure CBD (Hemp Oil) are few and far between, researchers say that the cannabinoid wouldn’t be to blame alone. “Reported adverse effects may be as a result of drug-drug interactions between CBD and patients’ existing medications,” they noted.


NORML reported, that the WHO is currently considering changing CBD’s place in its own drug scheduling code. In September, NORML submitted written testimony to the U.S. Food and Drug Administration (FDA) opposing the enactment of international restrictions on access to CBD.


Oddly enough, the FDA, which has repeatedly declined to update its position on cannabis products, despite the ever-growing body of evidence on the subject, is one of a number of agencies that will be advising the WHO in its final review of CBD.


Perhaps this time around the FDA will listen, and learn something.


If you are serious about deriving the benefits of CBD, you can balance your ECS (endocannabinoid system) with Blue Moon Hemp CBD. Blue Moon Hemp carries limited edition CBD and hemp oil, vape supplies, and is your one stop online shopping CBD store. They specialize in CBD oil, hemp oil, vape oil, vape oil refills, eliquid, e-liquid refills, CBD tincture and CBD shatter.